-
AYTU Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Aytu BioPharma (AYTU)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 20.11 mm | 20.11 mm | 20.11 mm | 20.11 mm | ||
Cash burn (monthly) | 290.42 k | (no burn) | 300.92 k | 25.00 k | ||
Cash used (since last report) | 818.24 k | n/a | 847.82 k | 70.44 k | ||
Cash remaining | 19.29 mm | n/a | 19.26 mm | 20.04 mm | ||
Runway (months of cash) | 66.4 | n/a | 64.0 | 801.5 |
13F holders | Current |
---|---|
Total holders | 15 |
Opened positions | 6 |
Closed positions | 17 |
Increased positions | 1 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 5.36 bn |
Total shares | 5.14 mm |
Total puts | 0.00 |
Total calls | 81.63 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
CVI Investments | 3.28 mm | $0.00 |
Nantahala Capital Management | 1.09 mm | $3.17 bn |
Stonepine Capital Management | 472.47 k | $1.38 bn |
Armistice Capital | 252.00 k | $735.84 mm |
Integrated Core Strategies | 22.87 k | $226.00 k |
Citadel Advisors | 21.81 k | $63.47 mm |
RY Royal Bank of Canada | 3.29 k | $10.00 mm |
MS Morgan Stanley | 440.00 | $1.29 mm |
BAC Bank of America | 92.00 | $269.00 k |
Group One Trading | 37.00 | $108.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Nov 24 | Ryan J Selhorn | Common Shares | Grant | Acquire A | No | No | 0 | 14,000 | 0.00 | 15,895 |
6 Nov 24 | Greg Pyszczymuka | Employee Stock Option Common Shares | Grant | Acquire A | No | No | 1.84 | 7,000 | 12.88 k | 7,000 |
6 Nov 24 | Vivian H Liu | Common Shares | Grant | Acquire A | No | No | 0 | 1,500 | 0.00 | 9,825 |
6 Nov 24 | Jarrett Disbrow | Employee Stock Option Common Shares | Grant | Acquire A | No | No | 1.84 | 7,000 | 12.88 k | 7,000 |